1-beta-D-arabinofuranosylcytosine (ara-C) deamination in human leukemic myeloblasts is not a mechanism of resistance to ara-C therapy.
D001853:Bone Marrow / Q000187:drug effects / Q000378:metabolism; D002478:Cells, Cultured; D003561:Cytarabine / Q000378:metabolism*; D003641:Deamination; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000378:metabolism*; D013767:Tetrahydrouridine / Q000494:pharmacology
D003561:Cytarabine; D013767:Tetrahydrouridine